Wealth Enhancement Advisory Services
RCUS icon

Wealth Enhancement Advisory Services’s Arcus Biosciences RCUS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Buy
+9,079
New +$224K ﹤0.01% 3332

Other funds holding RCUS

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
SAM
Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Wealth Enhancement Advisory Services's RCUS Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 9,079 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #3332 among its holdings.

17 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Wealth Enhancement Advisory Services held 9,079 shares of Arcus Biosciences worth $263K as of Q2 2026.
  • Arcus Biosciences was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3332 holding.
  • 17 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.